Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00754832Phase 2Completed
A Phase 2 trial of HT-1001 in multiple sclerosis (MS), sponsored by Oregon Health & Science University. Started Sep 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00754832.